Correlation Between Zentalis Pharmaceuticals and Verve Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Verve Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Verve Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and Verve Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Zentalis and Verve is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Verve Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Verve Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Verve Therapeutics. In addition to that, Zentalis Pharmaceuticals is 1.25 times more volatile than Verve Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Verve Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest 611.00 in Verve Therapeutics on December 5, 2024 and sell it today you would earn a total of 1.00 from holding Verve Therapeutics or generate 0.16% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Verve Therapeutics
Performance |
Timeline |
Zentalis Pharmaceuticals |
Verve Therapeutics |
Zentalis Pharmaceuticals and Verve Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zentalis Pharmaceuticals and Verve Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Money Managers Screen money managers from public funds and ETFs managed around the world |